HemOnc Today Current Issue

The following articles appeared in the print edition of HemOnc Today.

Table of Contents

• Primary care finds a home within cancer center Jennifer Byrne
• Can oncology rescue primary care? Barbara L. McAneny, MD, FASCO, MACP
• A Christmas tale of an oncologist, a dog and a surprise under the tree Nicholas J. Petrelli, MD, FACS
• Acetaminophen may reduce immunotherapy efficacy in patients with cancer Jennifer R. Southall
• Anxiety, distress common among caregivers of patients with multiple myeloma Jennifer R. Southall
• Black patients with metastatic breast cancer often not informed of clinical trials Jennifer R. Southall
• Cancer organizations ‘enthusiastically endorse’ Monica M. Bertagnolli, MD, as NCI director
• Concizumab prophylaxis reduces bleeds in hemophilia population ‘with complex treatment needs’ Drew Amorosi
• Continued CDK 4/6 inhibition after breast cancer progression may benefit some patients Devin McLaughlin
• Cardiovascular disease, not cancer, top cause of death among Hodgkin lymphoma survivors Jennifer R. Southall
• Efanesoctocog alfa shows superior bleed protection in severe hemophilia A Drew Amorosi
• FDA approves Xalkori for ALK-positive inflammatory myofibroblastic tumors
• FDA warns about potential elevated risk for death with blood cancer therapy
• First-line brentuximab vedotin regimen extends OS in advanced classical Hodgkin lymphoma Mark Leiser
• Fitusiran prophylaxis leads to 61% reduction in bleeds among people with hemophilia A or B Drew Amorosi
• ICER report: Evidence adequate of beti-cel benefit for patients with beta-thalassemia
• MD Anderson again ranked best cancer hospital in US
• Medicaid expansion under ACA appears to improve cancer clinical trial access Jennifer R. Southall
• Oncolytic adenovirus shows potential in pediatric diffuse intrinsic pontine glioma Jennifer R. Southall
• Pembrolizumab regimen fails to extend EFS in head and neck cancer subset
• Shared decision-making required when choosing first-line regimen for PD-L1-high NSCLC Mark Leiser
• Some older women with luminal A breast cancer can safely forgo radiotherapy, study shows Devin McLaughlin
• Tislelizumab regimen extends OS in advanced esophageal cancer
• Tovorafenib induces response in relapsed pediatric low-grade glioma
• Breast cancer specialist to receive lecture award
• Cancer center appoints associate director for diversity, equity and inclusion
• Cleveland Clinic appoints oncologist as chair of Taussig Cancer Institute
• Florida Cancer Specialists & Research Institute names vice president of nursing
• Roswell Park appoints cell therapy specialist as senior vice president
• UH Seidman Cancer Center names division chief, immunotherapy center director